Influence of circulating c-erbB-2 serum protein on response to adjuvant chemotherapy in node-positive breast cancer patients

By Fehm T.  

Breast Cancer Research and Treatment, Vol. 43, Iss. 1, 1997-03 ,pp. : 87-95

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the international Breast Cancer Study Group (IBCSG) trial VI

By Pagani O.   O'Neill A.   Castiglione M.   Gelber R.D.   Goldhirsch A.   Rudenstam C.-M.   Lindtner J.   Collins J.   Crivellari D.   Coates A.   Cavalli F.   Thurlimann B.   Simoncini E.   Fey M.   Price K.   Senn H.-J.  

European Journal of Cancer, Vol. 34, Iss. 5, 1998-04 ,pp. : 632-640

Elsevier

Access to resources Recommend Favorite

Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer

By Ananda Sumitra   Steer Christopher  

The Women's Oncology Review, Vol. 5, Iss. 2, 2005-06 ,pp. : 109-111

Informa Healthcare

Access to resources Recommend Favorite

Long-term impact of chemotherapy-induced ovarian failure on bone mineral density (BMD) in premenopausal breast cancer patients. The effect of adjuvant clodronate treatment

By Vehmanen L.   Saarto T.   Elomaa I.   Makela P.   Valimaki M.   Blomqvist C.  

European Journal of Cancer, Vol. 37, Iss. 18, 2001-12 ,pp. : 2373-2378

Elsevier

Access to resources Recommend Favorite

Quality of adjuvant CMF chemotherapy for node-positive primary breast cancer: a population-based study

By Schaapveld Michael   Vries Elisabeth   Graaf Winette   Otter Renée   Willemse Pax  

Journal of Cancer Research and Clinical Oncology, Vol. 130, Iss. 10, 2004-10 ,pp. : 581-590

Springer Publishing Company

Access to resources Recommend Favorite